Illuminating protein space with a programmable generative model

John Ingraham(Intarcia Therapeutics (United States)), Max Baranov(Intarcia Therapeutics (United States)), Zak Costello(Intarcia Therapeutics (United States)), Karl W. Barber(Intarcia Therapeutics (United States)), Wujie Wang(Intarcia Therapeutics (United States)), Ahmed Ismail(Intarcia Therapeutics (United States)), Vincent Frappier(Intarcia Therapeutics (United States)), Dana M. Lord(Intarcia Therapeutics (United States)), Christopher Ng‐Thow‐Hing(Intarcia Therapeutics (United States)), Erik R. Van Vlack(Intarcia Therapeutics (United States)), Shan Tie(Intarcia Therapeutics (United States)), Vincent Xue(Intarcia Therapeutics (United States)), Sarah C. Cowles(Intarcia Therapeutics (United States)), Alan Leung(Intarcia Therapeutics (United States)), João V. Rodrigues(Intarcia Therapeutics (United States)), Claudio L. Morales-Pérez(Intarcia Therapeutics (United States)), Alex Ayoub(Intarcia Therapeutics (United States)), Robin Green(Intarcia Therapeutics (United States)), Katherine Puentes(Intarcia Therapeutics (United States)), Frank Oplinger(Intarcia Therapeutics (United States)), Nishant V. Panwar(Intarcia Therapeutics (United States)), Fritz Obermeyer(Intarcia Therapeutics (United States)), Adam Root(Intarcia Therapeutics (United States)), Andrew L. Beam(Intarcia Therapeutics (United States)), Frank J. Poelwijk(Intarcia Therapeutics (United States)), Gevorg Grigoryan(Intarcia Therapeutics (United States))
Nature
November 15, 2023
Cited by 395Open Access
Full Text

Abstract

, but the full potential of proteins is likely to be much greater. Accessing this potential has been challenging for both computation and experiments because the space of possible protein molecules is much larger than the space of those likely to have functions. Here we introduce Chroma, a generative model for proteins and protein complexes that can directly sample novel protein structures and sequences, and that can be conditioned to steer the generative process towards desired properties and functions. To enable this, we introduce a diffusion process that respects the conformational statistics of polymer ensembles, an efficient neural architecture for molecular systems that enables long-range reasoning with sub-quadratic scaling, layers for efficiently synthesizing three-dimensional structures of proteins from predicted inter-residue geometries and a general low-temperature sampling algorithm for diffusion models. Chroma achieves protein design as Bayesian inference under external constraints, which can involve symmetries, substructure, shape, semantics and even natural-language prompts. The experimental characterization of 310 proteins shows that sampling from Chroma results in proteins that are highly expressed, fold and have favourable biophysical properties. The crystal structures of two designed proteins exhibit atomistic agreement with Chroma samples (a backbone root-mean-square deviation of around 1.0 Å). With this unified approach to protein design, we hope to accelerate the programming of protein matter to benefit human health, materials science and synthetic biology.


Related Papers

No related papers found

Powered by citation graph analysis